Dr.Sanjay Mongia  Consultant Neurological  & GAMMA KNIFE  Surgeon , Mumbai  , India
Second most common neurological disorder –  Prevalence: ~1% (2.5 million) –  Incidence: 125,000-180,000 new cases per year –  Total annual epilepsy-associated costs: $12.5 billion •  Occurs at all ages
Epilepsy is usually controlled, but not cured, with medication, although  surgery   may be considered in difficult cases. About 50 million people worldwide have epilepsy at any one time. Epilepsy is usually controlled, but current estimates indicate that 20 - 30% of patients with epilepsy are refractory to all forms of medical therapy These medically intractable patients are candidates for surgical treatment in an attempt to achieve better seizure control
 
Development Education Driving Marriage Life expectancy
Seizures:  Transient occurrence of clinical symptoms due to abnormal neuronal behavior –  Convulsions: Seizures with prominent body movement –  Non-convulsive seizures: Seizures with minimal or no body  Movement Epilepsy : Brain disorder with an enduring predisposition  to generate epileptic seizures Epilepsy syndromes  : Groups of epileptic patterns of varying cause but similar course and response to treatment
Seizures  : synchronous, high frequency discharge of neurons from cortical or subcortical centres Non-epileptic seizures  :  result of extreme metabolic disturbance, eg - sedative/hypnotic drug withdrawal - meningitis, CVA - renal failure - fever (children)
Epileptic seizures  - primary disorder of recurrent seizures without a reversible metabolic cause (about 1% population) •  Causes of this hyperexcitability : - genetic (autosomal dominant genes) - congenital defects - severe head injury - ischemic injury, tumour
 
Loss of consciousness Fall, cry Muscular rigidity (tonic) Rhythmic jerking (clonic) Respiration inhibited Tongue bite/ incontinence/ injury can occur Usually lasts 1-3 minutes Postictal confusion
I nfarct
History –  Patient –  Eyewitness Physical/neuro exam EEG –  Photic stimulation –  Hyperventilation –  Sleep deprivation Imaging –  CT scan –  MRI Special studies –  Ictal SPECT –  PET Video-EEG monitoring –  Diagnostic –  Presurgical
Single seizure  : May or may not treat depending  on likelihood of recurrence Epilepsy  : –  Antiepileptic drugs –  Surgery –  Vagus nerve stimulation
Goal - no seizures, but ↓ drug side effects (60-80% patients obtain good seizure control) Diagnosis - drug selection (for seizure type) Clinical evaluation - drug trial period Plasma drug levels - narrow therapeutic range – monitor Compliance difficult - chronic disorder Withdrawing medication - weeks -> months
Phenytoin (Dilantin): oral, IV, fosphenytoin Carbamazepine (Tegretol): oral Valproic acid (Depakote): oral, IV Phenobarbital (Luminal): oral, IV Primidone (Mysoline): oral Ethosuximide (Zarontin): oral Benzodiazepines: Diazepam, lorazepam, clonazepam  (CZP) - oral, IV, rectal
Gabapentin (Neurontin) Lamotrigine (Lamictal) Topiramate (Topamax) Tiagabine (Gabitril) Levetiracetam (Keppra) Oxcarbazepine (Trileptal) Zonisamide (Zonegran) Felbamate (Felbatol)
Type of seizure/epileptic syndrome Potential side effects Frequency of dosing Comorbid conditions Drug interactions Age, gender Cost of drug
Side effects and drug interactions Drowsiness, confusion, ataxia, diplopia Most are metabolised in the liver, & induce liver enzymes -> ↑ metabolism of other drugs, including oral contraceptives Some are teratogenic (eg cleft palate), but seizures present risk for fetus Monotherapy is preferred, but 2 or more drugs may be used
Epilepsy that is resistant to medication (often 2 years duration and 2 drug trials) Epilepsy originating in a single area in the Brain. Area able to be removed without causing a new neurological problem
Another group of patients who might benefit are those whose seizures may be relatively well controlled but who have certain characteristic presentations or lesions that strongly suggest surgical intervention might be curative.  Clinical data  suggests  that continued medical therapy after failure to control seizures with aggressive trials of antiepileptic drugs (AEDs) is not optimal treatment of certain
Referral to an epileptologist Video-EEG telemetry Structural Imaging – MRI scan Functional Imaging – SPECT/PET scan Neuropsychology assessment If suitable for surgery – then referral to an epilepsy neurosurgeon.
Shrunken Hippocampus
Hippocampal atrophy and T2 signal change  ,specificty for mesial temporal sclerosis, >95%  good prognostic feature correlates with low risk of memory deficits  Volumetric measurements of hippocampus
 
Curative Temporal lobectomy Lesion removal “ Non-lesional” resection Hemispherectomy Corpus callosotomy Vagal Nerve Stimulator Gamma knife Treatment
 
 
 
 
 
 
 

Epilepsy

  • 1.
    Dr.Sanjay Mongia Consultant Neurological & GAMMA KNIFE Surgeon , Mumbai , India
  • 2.
    Second most commonneurological disorder – Prevalence: ~1% (2.5 million) – Incidence: 125,000-180,000 new cases per year – Total annual epilepsy-associated costs: $12.5 billion • Occurs at all ages
  • 3.
    Epilepsy is usuallycontrolled, but not cured, with medication, although surgery may be considered in difficult cases. About 50 million people worldwide have epilepsy at any one time. Epilepsy is usually controlled, but current estimates indicate that 20 - 30% of patients with epilepsy are refractory to all forms of medical therapy These medically intractable patients are candidates for surgical treatment in an attempt to achieve better seizure control
  • 4.
  • 5.
    Development Education DrivingMarriage Life expectancy
  • 6.
    Seizures: Transientoccurrence of clinical symptoms due to abnormal neuronal behavior – Convulsions: Seizures with prominent body movement – Non-convulsive seizures: Seizures with minimal or no body Movement Epilepsy : Brain disorder with an enduring predisposition to generate epileptic seizures Epilepsy syndromes : Groups of epileptic patterns of varying cause but similar course and response to treatment
  • 7.
    Seizures :synchronous, high frequency discharge of neurons from cortical or subcortical centres Non-epileptic seizures : result of extreme metabolic disturbance, eg - sedative/hypnotic drug withdrawal - meningitis, CVA - renal failure - fever (children)
  • 8.
    Epileptic seizures - primary disorder of recurrent seizures without a reversible metabolic cause (about 1% population) • Causes of this hyperexcitability : - genetic (autosomal dominant genes) - congenital defects - severe head injury - ischemic injury, tumour
  • 9.
  • 10.
    Loss of consciousnessFall, cry Muscular rigidity (tonic) Rhythmic jerking (clonic) Respiration inhibited Tongue bite/ incontinence/ injury can occur Usually lasts 1-3 minutes Postictal confusion
  • 11.
  • 12.
    History – Patient – Eyewitness Physical/neuro exam EEG – Photic stimulation – Hyperventilation – Sleep deprivation Imaging – CT scan – MRI Special studies – Ictal SPECT – PET Video-EEG monitoring – Diagnostic – Presurgical
  • 13.
    Single seizure : May or may not treat depending on likelihood of recurrence Epilepsy : – Antiepileptic drugs – Surgery – Vagus nerve stimulation
  • 14.
    Goal - noseizures, but ↓ drug side effects (60-80% patients obtain good seizure control) Diagnosis - drug selection (for seizure type) Clinical evaluation - drug trial period Plasma drug levels - narrow therapeutic range – monitor Compliance difficult - chronic disorder Withdrawing medication - weeks -> months
  • 15.
    Phenytoin (Dilantin): oral,IV, fosphenytoin Carbamazepine (Tegretol): oral Valproic acid (Depakote): oral, IV Phenobarbital (Luminal): oral, IV Primidone (Mysoline): oral Ethosuximide (Zarontin): oral Benzodiazepines: Diazepam, lorazepam, clonazepam (CZP) - oral, IV, rectal
  • 16.
    Gabapentin (Neurontin) Lamotrigine(Lamictal) Topiramate (Topamax) Tiagabine (Gabitril) Levetiracetam (Keppra) Oxcarbazepine (Trileptal) Zonisamide (Zonegran) Felbamate (Felbatol)
  • 17.
    Type of seizure/epilepticsyndrome Potential side effects Frequency of dosing Comorbid conditions Drug interactions Age, gender Cost of drug
  • 18.
    Side effects anddrug interactions Drowsiness, confusion, ataxia, diplopia Most are metabolised in the liver, & induce liver enzymes -> ↑ metabolism of other drugs, including oral contraceptives Some are teratogenic (eg cleft palate), but seizures present risk for fetus Monotherapy is preferred, but 2 or more drugs may be used
  • 19.
    Epilepsy that isresistant to medication (often 2 years duration and 2 drug trials) Epilepsy originating in a single area in the Brain. Area able to be removed without causing a new neurological problem
  • 20.
    Another group ofpatients who might benefit are those whose seizures may be relatively well controlled but who have certain characteristic presentations or lesions that strongly suggest surgical intervention might be curative. Clinical data suggests that continued medical therapy after failure to control seizures with aggressive trials of antiepileptic drugs (AEDs) is not optimal treatment of certain
  • 21.
    Referral to anepileptologist Video-EEG telemetry Structural Imaging – MRI scan Functional Imaging – SPECT/PET scan Neuropsychology assessment If suitable for surgery – then referral to an epilepsy neurosurgeon.
  • 22.
  • 23.
    Hippocampal atrophy andT2 signal change ,specificty for mesial temporal sclerosis, >95% good prognostic feature correlates with low risk of memory deficits Volumetric measurements of hippocampus
  • 24.
  • 25.
    Curative Temporal lobectomyLesion removal “ Non-lesional” resection Hemispherectomy Corpus callosotomy Vagal Nerve Stimulator Gamma knife Treatment
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.